Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: Pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest

European Journal of Contraception and Reproductive Health Care

Volumn 16, Issue 4, 2011, Pages 258-269

  Fraser, Ian S ^a   Parke, Susanne ^b   Mellinger, Uwe ^b   MacHlitt, Andrea ^b   Serrani, Marco ^b   Jensen, Jeffrey ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b BAYER PHARMA AG   (Germany)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Heavy menstrual bleeding; Oral contraceptive

Indexed keywords

DIENOGEST PLUS ESTRADIOL VALERATE; HEMATIN; NATAZIA; PLACEBO; QLAIRA; UNCLASSIFIED DRUG;

ACNE; ANEMIA; ANXIETY; ARTHRALGIA; ARTICLE; BACKACHE; BREAST TENDERNESS; BRONCHITIS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; FATIGUE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEADACHE; HUMAN; HYPERTENSION; INFLUENZA; MASTALGIA; MENORRHAGIA; MENSTRUATION DISORDER; META ANALYSIS; METRORRHAGIA; MIGRAINE; MULTICENTER STUDY (TOPIC); MYCOSIS; NAUSEA; OUTCOME ASSESSMENT; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHINOPHARYNGITIS; SIDE EFFECT; SINUSITIS; STATISTICAL SIGNIFICANCE; VAGINITIS; VIRUS INFECTION; VOMITING; WEIGHT GAIN;

ADULT; CONTRACEPTIVES, ORAL; DRUG COMBINATIONS; ESTRADIOL; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; IRON; MENORRHAGIA; MENSTRUAL HYGIENE PRODUCTS; MIDDLE AGED; NANDROLONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79960721784     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2011.591456     Document Type: Article

References (22)

1. Snowden R, Christian B, eds. Patterns and perceptions of menstruation. A World Health Organization International Collaborative Study . London: Croom Helm 1983.
2. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss - a population study. Variation at different ages and attempts to defi ne normality. Acta Obstet Gynecol Scand 1966;45:320-51.
3. Kadir RA, Aledort LM. Obstetrical and gynaecological bleeding: A common presenting symptom. Clin Lab Haematol 2000;22(Suppl. 1):12 - 6; discussion 30-2. (Pubitemid 32047112)
4. National Collaborating Centre for Women's and Children's Health. Heavy menstrual bleeding. Commissioned by the National Institute for Health and Clinical Excellence. Accessed 13 August 2010 from:
5. Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2006:CD003855.
6. Iyer V, Farquhar C, Jepson R. Oral contraceptive pills for heavy menstrual bleeding. Cochrane Database Syst Rev 2000:CD000154.
7. Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust N Z J Obstet Gynaecol 1991;31:66-70.
8. Hurskainen R, Grenman S, Komi I, et al. Diagnosis and treatment of menorrhagia. Acta Obstet Gynecol Scand 2007;86:749-57. (Pubitemid 46801790)
9. Ahrendt HJ, Makalova D, Parke S, et al. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: A seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception 2009;80: 436-44.
10. Palacios S, Wildt L, Parke S, e t al. Effi cacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A Phase III trial. Eur J Obstet Gynecol Reprod Biol 2010;149:57-62.
11. Jensen JT, Parke S, Mellinger U, Machlitt A, Fraser IS. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial. Obstet Gynecol 2011;117:777-87.
12. Fraser IS, Römer T, Parke S, et al. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomised, double-blind Phase III trial. Hum Reprod 2011;In Press.
13. Belsey EM, Farley TM. The analysis of menstrual bleeding patterns: A review. Contraception 1988;38:129-56.
14. Shaw STJ, Aaronson DE, Moyer DL. Quantitation of menstrual blood loss - further evaluation of the alkaline hematin method. Contraception 1972;5:497-513.
15. Kaunitz AM, Bissonnette F, Monteiro I, e t al. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: A rando mized controlled trial. Obstet Gynecol 2010;116: 625-32.
16. Reid PC, Virtanen-Kari S. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: A multiple analysis using total menstrual fl uid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG 2005;112:1121-5. (Pubitemid 41632669)
17. Lukes AS, Moore KA, Muse KN, et al. Tranexamic acid treatment for heavy menstrual bleeding: A randomized controlled trial. Obstet Gynecol 2010;116:865-75.
18. LYSTEDA (tranexamic acid) tablet. Prescribing information. Xanodyne Pharmaceuticals, Inc. Accessed 12 January 2011 from: www.xanodyne.com/pdf/ Lysteda.pdf
19. Shabaan MM, Zakherah MS, El-Nashar SA, Sayed GH. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: A randomized clinical trial. Contraception 2011;83:48-54.
20. Sayed GH, Zakherah MS, El-Nashar SA, Shaaban MM. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fi broid-related menorrhagia. Int J Gynaecol Obstet 2011;112:126-30.
21. Endrikat J, Shapiro H, Lukkari-Lax E, e t al. A Canadian, multicentre study comparing the effi cacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia. J Obstet Gynaecol Can 2009;31:340-7.
22. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97:734-9. (Pubitemid 20263124)